Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3830
-0.0170 (-4.25%)
At close: Apr 1, 2025, 4:00 PM
0.3903
+0.0073 (1.91%)
After-hours: Apr 1, 2025, 5:11 PM EDT

Bolt Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
15204349183-
Upgrade
Market Cap Growth
-51.84%-51.84%-13.15%-73.20%--
Upgrade
Enterprise Value
-7-15-56-99-5-
Upgrade
Last Close Price
0.380.541.121.304.90-
Upgrade
PS Ratio
1.902.665.408.55145.00-
Upgrade
PB Ratio
0.260.360.380.280.73-
Upgrade
P/TBV Ratio
0.360.360.380.280.73-
Upgrade
Debt / Equity Ratio
0.440.440.180.130.100.43
Upgrade
Asset Turnover
0.060.060.040.020.010.01
Upgrade
Quick Ratio
3.043.045.037.318.732.03
Upgrade
Current Ratio
3.213.215.177.478.872.25
Upgrade
Return on Equity (ROE)
-74.28%-74.28%-48.69%-41.79%-71.52%-212.22%
Upgrade
Return on Assets (ROA)
-32.88%-32.88%-24.57%-21.08%-32.74%-64.72%
Upgrade
Return on Capital (ROIC)
-39.60%-39.60%-29.12%-24.09%-37.30%-78.52%
Upgrade
Earnings Yield
-429.84%-308.19%-162.73%-179.94%-53.96%-
Upgrade
FCF Yield
-417.66%-299.47%-163.99%-160.25%-32.52%-
Upgrade
Buyback Yield / Dilution
-0.98%-0.98%-1.21%-12.54%-1479.05%-5.46%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q